Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer

Downregulation of human leukocyte antigen (HLA) class I is one mechanism of escaping anti-tumor immunity by tumor cells. This study was conducted to compare HLA class I expression in ductal carcinoma in situ (DCIS) and invasive breast carcinoma (IBC) and to evaluate its association with immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Song-Hee, Kim, Milim, Chung, Yul Ri, Woo, Ji Won, Choi, Hye Yeon, Park, So Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701770/
https://www.ncbi.nlm.nih.gov/pubmed/36437379
http://dx.doi.org/10.1038/s41598-022-24890-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701770/
https://www.ncbi.nlm.nih.gov/pubmed/36437379
http://dx.doi.org/10.1038/s41598-022-24890-3

Ejemplares similares